Analytica Bio-Energy (ABEC) Stock Price, News & Analysis

Company Overview

Analytica Bio-Energy, Inc. (OTCMKTS: ABEC) is a diversified bioenergy and biotechnology company focused on the development, production and commercialization of renewable fuels and high-value biochemicals. Leveraging proprietary fermentation and enzymatic processes, Analytica Bio-Energy converts a wide range of agricultural residues and sustainable feedstocks into advanced biofuels, specialty chemicals and performance additives. The company’s integrated approach combines upstream feedstock optimization with downstream purification to deliver scalable and cost-effective solutions for energy and industrial markets.

Founded in the early 2000s and headquartered in Houston, Texas, Analytica Bio-Energy has expanded its research and development footprint with laboratories in California and pilot-scale facilities in the Midwest. Over its history, the company has forged strategic collaborations with major universities and technology partners to refine its microbial strains and enhance process yields. These partnerships have enabled Analytica Bio-Energy to progress multiple product candidates through rigorous testing and toward commercial demonstration.

Analytica Bio-Energy’s core product offerings include next-generation biodiesel derived from non-food feedstocks, cellulosic ethanol, and a portfolio of biobased solvents and surfactants. The company’s differentiated bio-refinery platform is designed to retrofit existing petrochemical plants, facilitating a smoother transition to renewable inputs and minimizing capital expenditure for end users. By tailoring its process technology to regional feedstock availability, Analytica Bio-Energy serves customers across North America, Europe and the Asia-Pacific region, addressing both transportation fuel and specialty chemical markets.

Under the leadership of CEO Michael Turner and COO Dr. Sandra Lee, Analytica Bio-Energy has pursued a disciplined commercialization strategy focused on pilot plant scale-up, regulatory approvals and long-term offtake agreements. The executive team combines deep expertise in industrial biotechnology, chemical engineering and corporate finance, positioning the company to capitalize on growing global demand for sustainable energy solutions. With a commitment to environmental stewardship and innovation, Analytica Bio-Energy continues to advance its mission of delivering cleaner, renewable alternatives to traditional fossil-derived products.

Key Stats

• Today's Range: $0.0080 to $0.0080
• 50-Day Range: $0.0080 to $0.0080
• 52-Week Range: $0.01 to $0.03
• Volume: N/A
• Average Volume: 4,120 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABEC Stock Analysis - Frequently Asked Questions

How have ABEC shares performed this year?

Analytica Bio-Energy's stock was trading at $0.0080 on January 1st, 2025. Since then, ABEC stock has increased by 0.0% and is now trading at $0.0080.

How do I buy shares of Analytica Bio-Energy?

Shares of ABEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Analytica Bio-Energy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Analytica Bio-Energy investors own include Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Adamis Pharmaceuticals (ADMP), Digital Ally Inc./NV (DGLY) and FuelCell Energy (FCEL).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Internet Software & Services
• Sub-Industry: Computer Software
• Current Symbol: OTCMKTS:ABEC
• Previous Symbol: NYSE:ABEC
• CIK: N/A
• Web: N/A
• Phone: (905) 824-6200
• Fax: N/A
• Employees: 190,200
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A